Review on uremic toxins: classification, concentration, and interindividual variability.
BACKGROUND
The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, and in vivo experiments remains a major area of concern; errors at this level might result in incorrect decisions regarding therpeutic correction of uremia and related clinical complications.


METHODS
An encyclopedic list of uremic retention solutes was composed, containing their mean normal concentration (CN), their highest mean/median uremic concentration (CU), their highest concentration ever reported in uremia (CMAX), and their molecular weight. A literature search of 857 publications on uremic toxicity resulted in the selection of data reported in 55 publications on 90 compounds, published between 1968 and 2002.


RESULTS
For all compounds, CU and/or CMAX exceeded CN. Molecular weight was lower than 500 D for 68 compounds; of the remaining 22 middle molecules, 12 exceeded 12,000 D. CU ranged from 32.0 ng/L (methionine-enkephalin) up to 2.3 g/L (urea). CU in the ng/L range was found especially for the middle molecules (10/22; 45.5%), compared with 2/68 (2.9%) for a molecular weight <500 D (P < 0.002). Twenty-five solutes (27.8%) were protein bound. Most of them had a molecular weight <500 D except for leptin and retinol-binding protein. The ratio CU/CN, an index of the concentration range over which toxicity is exerted, exceeded 15 in the case of 20 compounds. The highest values were registered for several guanidines, protein-bound compounds, and middle molecules, to a large extent compounds with known toxicity. A ratio of CMAX/CU <4, pointing to a Gaussian distribution, was found for the majority of the compounds (74/90; 82%). For some compounds, however, this ratio largely exceeded 4 [e.g., for leptin (6.81) or indole-3-acetic acid (10.37)], pointing to other influencing factors than renal function, such as gender, genetic predisposition, proteolytic breakdown, posttranslation modification, general condition, or nutritional status.


CONCLUSIONS
Concentrations of retention solutes in uremia vary over a broad range, from nanograms per liter to grams per liter. Low concentrations are found especially for the middle molecules. A substantial number of molecules are protein bound and/or middle molecules, and many of these exert toxicity and are characterized by a high range of toxic over normal concentration (CU/CN ratio). Hence, uremic retention is a complex problem that concerns many more solutes than the current markers of urea and creatinine alone. This list provides a basis for systematic analytic approaches to map the relative importance of the enlisted families of toxins.
Vanholder
Raymond
R
The Nephrology Section, Department of Internal Medicine, University Hospital, Ghent, Belgium. raymond.vanholder@rug.ac.be
De Smet
Rita
R
Glorieux
Griet
G
Argilés
Angel
A
Baurmeister
Ulrich
U
Brunet
Philippe
P
Clark
William
W
Cohen
Gerald
G
De Deyn
Peter Paul
PP
Deppisch
Reinhold
R
Descamps-Latscha
Beatrice
B
Henle
Thomas
T
Jörres
Achim
A
Lemke
Horst Dieter
HD
Massy
Ziad A
ZA
Passlick-Deetjen
Jutta
J
Rodriguez
Mariano
M
Stegmayr
Bernd
B
Stenvinkel
Peter
P
Tetta
Ciro
C
Wanner
Christoph
C
Zidek
Walter
W
D006801:Humans; D051437:Renal Insufficiency / Q000378:metabolism*; D014118:Toxins, Biological / Q000145:classification* / Q000378:metabolism*; D014511:Uremia / Q000378:metabolism*
D014118:Toxins, Biological